Healthcare news, data and analysis
Via Investors in Healthcare
UK: Stow Healthcare Group sold to CGEN Care Group
Stow Healthcare Group, a privately held residential care group that owns and operates a collection of exclusive nursing, residential and memory care homes in the East of England, has been sold […]
Stow Healthcare Group, a privately held residential care group that owns and operates a collection of exclusive nursing, residential and memory care homes in the East of England, has been sold […]
UK: Stow Healthcare Group sold to CGEN Care Group
May 15, 2025
Care Homes
M&A
M&A Deals
News
Real Estate
Luxembourg: Evolution announced at Astorg’s leadership team
European private equity firm, Luxembourg-headquartered Astorg, has announced an evolution of its leadership team as part of its long-term development strategy. Thierry Timsit, co-founder of the firm and currently CEO, […]
European private equity firm, Luxembourg-headquartered Astorg, has announced an evolution of its leadership team as part of its long-term development strategy. Thierry Timsit, co-founder of the firm and currently CEO, […]
Luxembourg: Evolution announced at Astorg’s leadership team
May 15, 2025
Healthcare
Life Sciences
People
Pharma
Astorg
UK: Mansfield Advisors promotes Ali Bahram to associate partner
Mansfield Advisors, the UK-based strategy consulting firm across healthcare (including social care and education), life sciences and veterinary, has promoted Ali Bahram to associate partner. Bahram has been with Mansfield […]
Mansfield Advisors, the UK-based strategy consulting firm across healthcare (including social care and education), life sciences and veterinary, has promoted Ali Bahram to associate partner. Bahram has been with Mansfield […]
UK: Mansfield Advisors promotes Ali Bahram to associate partner
May 15, 2025
Education
Healthcare
Life Sciences
People
Social Care
Metric Capital Partners, a pan-European private capital investment firm, has announced the final close of MCP V and its ancillary vehicles at its target size with total commitments of €1bn […]
Germany: Funds advised by Nord Holding acquire Rigeto’s stake in OR Technology
Funds advised by Nord Holding have acquired Rigeto’s stake in OR Technology, a provider of digital X-ray imaging and image management systems and becomes a strategic partner to OR’s management […]
Funds advised by Nord Holding have acquired Rigeto’s stake in OR Technology, a provider of digital X-ray imaging and image management systems and becomes a strategic partner to OR’s management […]
Germany: Funds advised by Nord Holding acquire Rigeto’s stake in OR Technology
May 13, 2025
Buy Out
Life Sciences
M&A
Medtech – Hospital Equipment
News
The Netherlands: Azafaros secures €132m in oversubscribed Series B
Azafaros, a clinical-stage company focused on developing disease-modifying therapeutics to offer new treatment options to patients with rare lysosomal storage disorders, has completed an oversubscribed €132m (US$147m) Series B financing […]
Azafaros, a clinical-stage company focused on developing disease-modifying therapeutics to offer new treatment options to patients with rare lysosomal storage disorders, has completed an oversubscribed €132m (US$147m) Series B financing […]
The Netherlands: Azafaros secures €132m in oversubscribed Series B
May 13, 2025
Manufacturing – Specialty Pharma
News
Pharma
Venture
Azafaros
Italy: Riverside builds BioDue with Biokosmes and Rolf Kullgren
Riverside, a US-based global investment firm focused on the smaller end of the middle market, has announced that its portfolio company, BioDue, an Italian CDMO specialized in the commercialization of food […]
Riverside, a US-based global investment firm focused on the smaller end of the middle market, has announced that its portfolio company, BioDue, an Italian CDMO specialized in the commercialization of food […]
Italy: Riverside builds BioDue with Biokosmes and Rolf Kullgren
May 13, 2025
Buy Out
M&A
News
Pharma
Services – CRO/CMO/CDMO
Switzerland: DocMorris aims for CH200m from rights issue
Switerland headquartered online pharmacy, DocMorris, is looking to raise around CHF200m (US$237m) through a rights issue. The capital increase will be used to finance the planned medium-term growth in the […]
Switerland headquartered online pharmacy, DocMorris, is looking to raise around CHF200m (US$237m) through a rights issue. The capital increase will be used to finance the planned medium-term growth in the […]
Switzerland: DocMorris aims for CH200m from rights issue
May 12, 2025
Healthcare
News
Pharmacy
Public Equity
Bank of America
Sweden: Safe Life goes on acquisition spree
Safe Life, a Stockholm-based provider of life-saving solutions with portfolio companies across Europe and North America, has been on an acquisition spree as it pursues its ambitious growth strategy across Europe and beyond. The […]
Safe Life, a Stockholm-based provider of life-saving solutions with portfolio companies across Europe and North America, has been on an acquisition spree as it pursues its ambitious growth strategy across Europe and beyond. The […]
Sweden: Safe Life goes on acquisition spree
May 12, 2025
Life Sciences
M&A
Medtech – Hospital Equipment
Medtech – Medical Devices and Implants
News
Spain: Miura Partners provides capital in support of Saesco growth strategy
Spain-based Miura Partners has provided a capital increase for Barcelona-headquartered Saesco Medical, a European group specialised in the distribution of medical devices and consumables for minimally invasive surgery, in support […]
Spain-based Miura Partners has provided a capital increase for Barcelona-headquartered Saesco Medical, a European group specialised in the distribution of medical devices and consumables for minimally invasive surgery, in support […]
Spain: Miura Partners provides capital in support of Saesco growth strategy
May 12, 2025
Distribution
Healthcare
M&A
News
Venture
US: News reports point to Bain seeking majority stake in PCI Pharma
News reports, referencing Bloomberg, point to Bain Capital looking to acquire PCI Pharma Services for US$10bn. PCI Pharma is a US-based global CDMO backed by Kohlberg, Mubadala Investment Company and […]
News reports, referencing Bloomberg, point to Bain Capital looking to acquire PCI Pharma Services for US$10bn. PCI Pharma is a US-based global CDMO backed by Kohlberg, Mubadala Investment Company and […]
US: News reports point to Bain seeking majority stake in PCI Pharma
May 12, 2025
M&A
News
Pharma
Services – CRO/CMO/CDMO
Bain Capital
Belgium: Cofinimmo rejects Aedifica non‐binding exchange offer
Cofinimmo has rejected the unsolicited exchange offer proposed by Aedifica. Although it acknowledges the strategic rationale, considers the terms proposed by Aedifica undervalues Cofinimmo and its future prospects, and presents […]
Cofinimmo has rejected the unsolicited exchange offer proposed by Aedifica. Although it acknowledges the strategic rationale, considers the terms proposed by Aedifica undervalues Cofinimmo and its future prospects, and presents […]
Belgium: Cofinimmo rejects Aedifica non‐binding exchange offer
May 9, 2025
Care Homes
M&A
M&A Deals
News
Public Equity
Sweden: Ulrika Kolsrud: new president and CEO of Essity
Essity, a provider of products and solutions for health, hygiene and well-being, hasappointed Ulrika Kolsrud as president and CEO. She will assume her position on June 1, 2025, based at Essity’s head office in Stockholm. She […]
Essity, a provider of products and solutions for health, hygiene and well-being, hasappointed Ulrika Kolsrud as president and CEO. She will assume her position on June 1, 2025, based at Essity’s head office in Stockholm. She […]
Sweden: Ulrika Kolsrud: new president and CEO of Essity
May 9, 2025
Consumer Healthcare
Cosmetic & Aesthetics
Healthcare
People
Essity
France: Charterhouse welcomes minority investors into Novétude Group
Charterhouse Capital Partners, a private equity firm with a growth-focused approach to mid-market European companies across the services and healthcare sectors, has announced that Peugeot Invest, the listed investment company […]
Charterhouse Capital Partners, a private equity firm with a growth-focused approach to mid-market European companies across the services and healthcare sectors, has announced that Peugeot Invest, the listed investment company […]
France: Charterhouse welcomes minority investors into Novétude Group
May 9, 2025
Education
Healthcare
News
Venture
Charterhouse Capital Partners
Germany: VVC appoints Barbara Krebs-Pohl as partner and managing director for Germany
Viopas Venture Consulting (VVC), a Switzerland-headquartered provider of strategic, operational, business and finance advice to companies in the Life Sciences and related sectors, has appointed Barbara Krebs-Pohl, PhD as partner […]
Viopas Venture Consulting (VVC), a Switzerland-headquartered provider of strategic, operational, business and finance advice to companies in the Life Sciences and related sectors, has appointed Barbara Krebs-Pohl, PhD as partner […]
Germany: VVC appoints Barbara Krebs-Pohl as partner and managing director for Germany
May 8, 2025
People
Pharma
Barbara Krebs-Pohl
Germany
Viopas Venture Consulting
Finland: Northern Horizon adds portfolio of Finnish healthcare assets to new evergreen fund
Northern Horizon, a specialized healthcare asset manager in the Nordics, has acquired a Finnish portfolio of healthcare properties for its new evergreen healthcare fund, Aged Care and Social Infrastructure Fund, […]
Northern Horizon, a specialized healthcare asset manager in the Nordics, has acquired a Finnish portfolio of healthcare properties for its new evergreen healthcare fund, Aged Care and Social Infrastructure Fund, […]
Finland: Northern Horizon adds portfolio of Finnish healthcare assets to new evergreen fund
May 8, 2025
Buy Out
Care Homes
M&A
M&A Deals
News
France: Præmia Healthcare completes 2025 refinancing plan with €190m debt issuance
Præmia Healthcare has completed its refinancing plan for 2025 with the issuance of a €100m (US$113m) 10-year private placement paying a coupon of 4.632%, and a €90m sustainability-linked loan. The […]
Præmia Healthcare has completed its refinancing plan for 2025 with the issuance of a €100m (US$113m) 10-year private placement paying a coupon of 4.632%, and a €90m sustainability-linked loan. The […]
France: Præmia Healthcare completes 2025 refinancing plan with €190m debt issuance
May 8, 2025
Care Homes
News
Real Estate
Social Care
France
US: Eliquent Life Sciences acquires Azzur Consulting strengthening full-service quality & compliance capabilities
GHO Capital portfolio company Eliquent Life Sciences, a US-headquartered quality, compliance and regulatory affairs consulting firm, has acquired US-based Azzur Consulting, a quality and validation engineering firm that partners with leading pharmaceutical, biotechnology, […]
GHO Capital portfolio company Eliquent Life Sciences, a US-headquartered quality, compliance and regulatory affairs consulting firm, has acquired US-based Azzur Consulting, a quality and validation engineering firm that partners with leading pharmaceutical, biotechnology, […]
US: Eliquent Life Sciences acquires Azzur Consulting strengthening full-service quality & compliance capabilities
May 7, 2025
Buy Out
Life Sciences
M&A
News
Pharma
France: Astorg to acquire biotech ingredient solutions provider Solabia
Astorg, a pan-European private equity firm, has signed a definitive agreement to acquire a majority stake in France-based Solabia Group, a global biotechnology ingredient solutions provider, from TA Associates, a […]
Astorg, a pan-European private equity firm, has signed a definitive agreement to acquire a majority stake in France-based Solabia Group, a global biotechnology ingredient solutions provider, from TA Associates, a […]
France: Astorg to acquire biotech ingredient solutions provider Solabia
May 7, 2025
Cosmetic & Aesthetics
Healthcare
M&A
News
Pharma
Turkey: FutureLife Group accelerates growth with strategic acquisition of Bahceci Group
FutureLife, a pan-European provider of fertility, IVF and genetics services, backed by CVC Capital Partners and Hartenberg Holding, is accelerating growth with the strategic acquisition of the Bahceci Group in Turkey, Kosovo, […]
FutureLife, a pan-European provider of fertility, IVF and genetics services, backed by CVC Capital Partners and Hartenberg Holding, is accelerating growth with the strategic acquisition of the Bahceci Group in Turkey, Kosovo, […]
Turkey: FutureLife Group accelerates growth with strategic acquisition of Bahceci Group
May 7, 2025
Buy Out
Fertility
Healthcare
M&A
News
UAE: M42 appoints Moulavasilis as group CEO, Romanini takes up CEO seat at Diaverum
M42, the Abu Dhabi-based global healthcare company, has appointed Dimitris Moulavasilis as the company’s new group CEO, replacing Hasan Jasem Al Nowais as he transitions from his role to continue as […]
M42, the Abu Dhabi-based global healthcare company, has appointed Dimitris Moulavasilis as the company’s new group CEO, replacing Hasan Jasem Al Nowais as he transitions from his role to continue as […]
UAE: M42 appoints Moulavasilis as group CEO, Romanini takes up CEO seat at Diaverum
May 7, 2025
Healthcare
Hospitals and Clinics
Life Sciences
Medtech – Hospital Equipment
Medtech – Medical Devices and Implants
Poland: Enterprise Investors Fund IX closes at €340m
One of the largest equity investors in Central and Eastern Europe, Enterprise Investors (EI), has announced the final close of Enterprise Investors Fund IX (EIF IX) at €340m (US$385m). EIF […]
One of the largest equity investors in Central and Eastern Europe, Enterprise Investors (EI), has announced the final close of Enterprise Investors Fund IX (EIF IX) at €340m (US$385m). EIF […]
Poland: Enterprise Investors Fund IX closes at €340m
May 6, 2025
Buy Out
Dental
Healthcare
News
Venture
UK: FibroFind receives investment from Vespa Capital to accelerate growth plans
Vespa Capital, a private equity investor in the UK lower mid-market, has invested in FibroFind, a UK-based globally recognised pre-clinical CRO. Incorporated as a spin-out from Newcastle University in 2019 […]
Vespa Capital, a private equity investor in the UK lower mid-market, has invested in FibroFind, a UK-based globally recognised pre-clinical CRO. Incorporated as a spin-out from Newcastle University in 2019 […]
UK: FibroFind receives investment from Vespa Capital to accelerate growth plans
May 6, 2025
Debt
News
Pharma
Services – CRO/CMO/CDMO
Venture
Sweden: Nrep invests in Swedish care home developer Sehlhall
Nrep, the real estate investment arm of Urban Partners, has entered into a strategic partnership with Swedish care home developer Sehlhall Fastigheter., with the ambition to become Sweden’s leading later […]
Nrep, the real estate investment arm of Urban Partners, has entered into a strategic partnership with Swedish care home developer Sehlhall Fastigheter., with the ambition to become Sweden’s leading later […]
Sweden: Nrep invests in Swedish care home developer Sehlhall
May 6, 2025
Care Homes
News
Real Estate
Retirement Housing
Social Care
Austria: Asker bolts MS Labors onto Heintel
Stockholm-listed Asker Healthcare Group has acquired 100% of the shares in Melet Schloesing Laboratories (MS Labors), a small niche distributor of point-of-care testing equipment and consumables in Austria. MS Labors […]
Stockholm-listed Asker Healthcare Group has acquired 100% of the shares in Melet Schloesing Laboratories (MS Labors), a small niche distributor of point-of-care testing equipment and consumables in Austria. MS Labors […]
Austria: Asker bolts MS Labors onto Heintel
May 6, 2025
Life Sciences
M&A
Medtech – Hospital Equipment
Medtech – Medical Devices and Implants
News
Our Sectors
We are experts at what we do
01
Our People
A dedicated team of executive search experts, delivering for you
The Compass Carter Osborne team are healthcare and life science experts. As a trusted advisor we bring decades of search experience and an unparalleled track record of delivery across our dedicated sectors for our investor clients – relied upon time and again to build outstanding leadership teams.
Familiar faces at key industry events, our expertise extends beyond the mere placing of people with our consultants bringing together sector leaders to address key challenges, working in partnership to produce tangible solutions.
02
Expertise
Unearthing rare talent, that drive successful exits
Responsive, adaptable, and emotionally intelligent, Compass Carter Osborne avoid the one-size-fits-all approach to ensure our clients achieve their desired outcome by presenting a broad range of intuitive, tailored solutions, based on specific needs.
03
Our Approach
Tailoring our offering,
to provide a bespoke service
Results driven, not process led, CCO avoid the conformity of a rigid process. Never assumptive, we listen and adopt an agreed approach which most closely delivers to a clients specific needs. Understanding the uniqueness of each role, our people tailor a search to bespoke requirements to ensure solutions that delivers the best possible results first time, every time.
A trusted advisor to the investment community
providing leaders advancing the healthcare and life sciences sectors
What our clients say
“Compass Carter Osborne really delivered for us in our search for a new CEO for Outcomes First Group. It was a vitally important assignment given that we were recruiting a successor for a long standing and highly successful CEO in a sector-leading business. Compass Carter Osborne went above and beyond in developing a deep understanding of the business and our requirements, and in only presenting candidates that closely met these. They think very creatively and their focus was very sharp; they particularly understood the culture of the business. The search was speedy and well organised, with a very high standard of verbal and written feedback. They have a granular knowledge of the sector and because of the way in which they work, we were fully involved throughout and achieved a great result. A really excellent search – thank you.”
Outcomes First Group – Chair
“Compass Carter Osborne started from the very beginning with a detailed, professional explanation of the available position. They spent time to present the great opportunity and chance to accelerate my career but at the same time, the challenge, and the strong expectation from their client.”
Hengrui Therapeutics – VP, Head Biological Drug Discovery
“Compass Carter Osborne delivered on a key appointment for the PFA and the wider football industry. It was a complex brief involving creating an entirely new position. The role was vitally important, with the successful candidate taking on a sensitive and multifaceted responsibility across CTE, concussion and brain health in professional football. CCO led a comprehensive and exhaustive process, developing a deep understanding of the union’s requirements and using his expert knowledge to help scope and evolve the brief throughout the search. The entire process was professional, efficient and well organised, with consistent communication and feedback at every stage.”
The Professional Footballers Association (PFA) – Chief Executive Officer
“I have been so impressed by Luke’s integrity, clear purpose and drive to achieve for his clients. Luke has worked with Priory on a number of things but more recently to source two independent Non Executive Directors and a Director of Talent Acquisition. He has kept us informed, fielded some great candidates and follows up at each stage, even when they have started. I would really recommend him if you are searching for high calibre individuals.”
Priory Group – Chief Executive Officer
“I recently had the pleasure of being appointed to an independent healthcare provider as a NED after being put forward for the role by Luke. Throughout the whole recruitment process I was treated with respect and felt valued. I was particularly impressed with the follow up support after the decision to appoint me, which I have never experienced from other search companies. Luke continued to check in with me to ensure my onboarding went smoothly and that I had settled into the role. Overall, a highly professional and comprehensive approach delivered personally by Luke.”
Priory – Independent Non-Executive Director
“Luke was absolutely brilliant along the journey. He acted as a real partner and was able to answer to all my questions in order to get comfortable with the decision of making the change. His expertise and knowledge of the sector really came out along the process. Most importantly, he was always available when I needed him to be, which is something I valued a lot. In summary, I couldn’t recommend him and Compass Carter Osborne enough.”
AniCura – Group Chief Operating Officer
“We worked with Compass Carter Osborne in the search for our Chief Financial Officer and from the start it was clear they were a good choice of partner. A focus on understanding our needs as a business, and mine personally as a CEO were front of mind for Paul and Kieran. They took the time to listen, understand and not only focus on the functional aspects of the role – but critically, the team fit and culture we are building.
Process, structure and follow-through were like clockwork, and the quality of candidates were of a consistently high-level. I would highly recommend Compass Carter Osborne.”
Renaiss Health – Chief Executive Officer
“I’ve known Tarquin for over 15 years, during which time he has delivered a number of executive assignments at senior level, including COO/executive team and senior management roles in scientific/professional disciplines (his network in the biotech/life-sciences sector is second-to-none!). He works hard to truly understand both the candidate brief and the culture of the company, sets realistic expectations and retains regular contact as an assignment progresses, always providing thorough updates and pragmatic advice. He has the highest levels of professionalism and integrity – he really is a pleasure to work with.”
One Nucleus – Director
“Jamie did a great job – he really took the time to understand our business, our needs and what we were looking for. We knew our brief was specific, yet Jamie met all our expectations with the search. He maintained a high standard of communication and meticulous attention to detail throughout the process. I would recommend Jamie and the Compass Carter Osborne team without hesitation.”
Melrose Education – Chair & CEO
“Our recent work with Compass Carter Osborne was exceptional. The search was perfectly organised, response times were swift, and due to the consultant market knowledge and network, we quickly found our ideal candidate.”
Schoen Clinic – Member of Group Executive
